Literature DB >> 21306701

Patient safety in obstetrics--the Hospital Corporation of America experience.

Steven L Clark1, Janet A Meyers, Donna K Frye, Jonathan A Perlin.   

Abstract

We report an update on obstetric patient safety efforts and results in the nation's largest obstetric health care delivery system. The application of principles advocated by the Institute of Medicine a decade ago has resulted in reduced adverse outcomes, as reflected by claims experience. Particular progress has been made in standardization and documentation of critical processes, establishment of national quality benchmarks, reduction in elective deliveries <39 weeks' gestation, and reduction in fatal postcesarean pulmonary embolism. Our experience provides a useful blueprint for similar progress in other health care systems.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21306701     DOI: 10.1016/j.ajog.2010.12.034

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  A Statewide Quality Improvement Initiative to Reduce Non-Medically Indicated Scheduled Deliveries.

Authors:  Marilyn A Kacica; J Christopher Glantz; Kuangnan Xiong; Eileen P Shields; Peter H Cherouny
Journal:  Matern Child Health J       Date:  2017-04

2.  Changes in Hospital Income, Use, and Quality Associated With Private Equity Acquisition.

Authors:  Joseph D Bruch; Suhas Gondi; Zirui Song
Journal:  JAMA Intern Med       Date:  2020-11-01       Impact factor: 44.409

3.  Quality of obstetric care in the sparsely populated sub-arctic area of Norway 2009-2011.

Authors:  Jan Norum; Anca Heyd; Bente Hjelseth; Tove Svee; Fred A Mürer; Randi Erlandsen; Barthold Vonen
Journal:  BMC Pregnancy Childbirth       Date:  2013-09-14       Impact factor: 3.007

4.  Electronic Fetal Monitoring Credentialing Examination: The First 4000.

Authors:  Mark W Tomlinson; Sara A Brumbaugh; Marin O'Keeffe; Richard L Berkowitz; Mary D'Alton; Michael Nageotte
Journal:  AJP Rep       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.